{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:26:18Z","timestamp":1786980378225,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,9,22]],"date-time":"2009-09-22T00:00:00Z","timestamp":1253577600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1007\/s00702-009-0315-9","type":"journal-article","created":{"date-parts":[[2009,9,21]],"date-time":"2009-09-21T09:42:21Z","timestamp":1253526141000},"page":"45-51","source":"Crossref","is-referenced-by-count":6,"title":["Expression of catechol-O-methyltransferase in the brain and periphery of normal and MPTP-treated common marmosets"],"prefix":"10.1007","volume":"117","author":[{"given":"Bai-Yun","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Balfour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike J.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Jenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,9,22]]},"reference":[{"key":"315_CR1","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1523\/JNEUROSCI.23-06-02008.2003","volume":"23","author":"M Akil","year":"2003","unstructured":"Akil M, Kolachana BS, Rothmond DA, Hyde TM, Weinberger DR, Kleinman JE (2003) Catechol-O-methyltransferase genotype and dopamine regulation in the human brain. J Neurosci 23:2008\u20132013","journal-title":"J Neurosci"},{"key":"315_CR2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1527-3458.2007.00020.x","volume":"13","author":"MJ Bonif\u00e1cio","year":"2007","unstructured":"Bonif\u00e1cio MJ, Palma PN, Almeida L, Soares-da-Silva P (2007) Catechol-O-methyltransferase and its inhibitors in Parkinson\u2019s disease. CNS Drug Rev 13:352\u2013379","journal-title":"CNS Drug Rev"},{"key":"315_CR3","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/0024-3205(74)90233-1","volume":"14","author":"RT Borchardt","year":"1974","unstructured":"Borchardt RT, Cheng CF, Cooke PH (1974) The purification and kinetic properties of liver microsomal-catechol-O-methyltransferase. Life Sci 14:1089\u20131100","journal-title":"Life Sci"},{"key":"315_CR4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/NDT.S1660","volume":"4","author":"DJ Brooks","year":"2008","unstructured":"Brooks DJ (2008) Optimizing levodopa therapy for Parkinson\u2019s disease with levodopa\/carbidopa\/entacapone: implications from a clinical and patient perspective. Neuropsychiatr Dis Treat 4:39\u201347","journal-title":"Neuropsychiatr Dis Treat"},{"key":"315_CR5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jpsychires.2005.03.005","volume":"41","author":"ML Chen","year":"2007","unstructured":"Chen ML, Chen CH (2007) Chronic antipsychotics treatment regulates MAOA, MAOB and COMT gene expression in rat frontal cortex. J Psychiatr Res 41:57\u201362","journal-title":"J Psychiatr Res"},{"key":"315_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euroneuro.2006.03.004","volume":"17","author":"MC Cheng","year":"2007","unstructured":"Cheng MC, Liao DL, Hsiung CA, Chen CY, Liao YC, Chen CH (2007) Chronic treatment with aripiprazole induces differential gene expression in the rat frontal cortex. Int J Neuropsychopharmacol 17:1\u201310","journal-title":"Int J Neuropsychopharmacol"},{"key":"315_CR7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0028-3908(97)00017-8","volume":"36","author":"DJ Doudet","year":"1997","unstructured":"Doudet DJ, Chan GL, Holden JE, Morrison KS, Wyatt RJ, Ruth TJ (1997) Effects of catechol-O-methyltransferase inhibition on the rates of uptake and reversibility of 6-fluoro-l-Dopa trapping in MPTP-induced parkinsonism in monkeys. Neuropharmacology 36:363\u2013371","journal-title":"Neuropharmacology"},{"issue":"13","key":"315_CR8","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/0006-2952(87)90157-2","volume":"36","author":"A Francis","year":"1987","unstructured":"Francis A, Whittemore R, Jeffery DR, Pearce LB, Roth JA (1987) Catecholamine-metabolizing enzyme activity in the nigrostriatal system. Biochem Pharmacol 36(13):2229\u20132231","journal-title":"Biochem Pharmacol"},{"key":"315_CR9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1471-4159.1985.tb05432.x","volume":"44","author":"MH Grossman","year":"1985","unstructured":"Grossman MH, Creveling CR, Rybczynski R, Braverman M, Isersky C, Breakefield XO (1985) Soluble and particulate forms of rat catechol-O-methyltransferase distinguished by gel electrophoresis and immune fixation. J Neurochem 44:421\u2013432","journal-title":"J Neurochem"},{"key":"315_CR10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0031-6997(25)06681-5","volume":"27","author":"HC Guldberg","year":"1975","unstructured":"Guldberg HC, Marsden CA (1975) Catechol-O-methyl transferase: pharmacological aspects and physiological role. Pharmacol Rev 27:135\u2013206","journal-title":"Pharmacol Rev"},{"key":"315_CR11","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1097\/00001756-199808240-00033","volume":"9","author":"J Hong","year":"1998","unstructured":"Hong J, Shu-Leong H, Tao X, Lap-Ping Y (1998) Distribution of catechol-O-methyltransferase expression in human central nervous system. Neuroreport 9:2861\u20132864","journal-title":"Neuroreport"},{"key":"315_CR12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0169-328X(01)00022-5","volume":"87","author":"MJ Hurley","year":"2001","unstructured":"Hurley MJ, Mash DC, Jenner P (2001) Dopamine D(1) receptor expression in human basal ganglia and changes in Parkinson\u2019s disease. Brain Res Mol Brain Res 87:271\u2013279","journal-title":"Brain Res Mol Brain Res"},{"key":"315_CR13","doi-asserted-by":"crossref","unstructured":"Jankovic J (2005) Motor fluctuations and dyskinesias in Parkinson\u2019s disease: clinical manifestations. Mov Disord 20 (Suppl) 11:S11\u20136","DOI":"10.1002\/mds.20458"},{"key":"315_CR14","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1471-4159.1984.tb02755.x","volume":"42","author":"DR Jeffery","year":"1984","unstructured":"Jeffery DR, Roth JA (1984) Characterization of membrane-bound and soluble catechol-O-methyltransferase from human frontal cortex. J Neurochem 42:826\u2013832","journal-title":"J Neurochem"},{"issue":"10","key":"315_CR15","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1021\/bi00384a042","volume":"26","author":"DR Jeffery","year":"1987","unstructured":"Jeffery DR, Roth JA (1987) Kinetic reaction mechanism for magnesium binding to membrane-bound and soluble catechol-O-methyltransferase. Biochemistry 26(10):2955\u20132958","journal-title":"Biochemistry"},{"key":"315_CR16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0304-3940(84)90467-1","volume":"50","author":"P Jenner","year":"1984","unstructured":"Jenner P, Rupniak NM, Rose S, Kelly E, Kilpatrick G, Lees A, Marsden CD (1984) 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced parkinsonism in the common marmoset. Neurosci Lett 50:85\u201390","journal-title":"Neurosci Lett"},{"key":"315_CR17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF01244343","volume":"69","author":"S Kaakkola","year":"1987","unstructured":"Kaakkola S, M\u00e4nnist\u00f6 PT, Nissinen E (1987) Striatal membrane-bound and soluble catechol-O-methyl-transferase after selective neuronal lesions in the rat. J Neural Transm 69:221\u2013228","journal-title":"J Neural Transm"},{"key":"315_CR18","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1177\/42.8.8027527","volume":"42","author":"T Karhunen","year":"1994","unstructured":"Karhunen T, Tilgmann C, Ulmanen I, Julkunen I, Panula P (1994) Distribution of catechol-O-methyltransferase enzyme in rat tissues. J Histochem Cytochem 42:1079\u20131090","journal-title":"J Histochem Cytochem"},{"key":"315_CR19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0304-3940(95)11337-V","volume":"187","author":"T Karhunen","year":"1995","unstructured":"Karhunen T, Tilgmann C, Ulmanen I, Panula P (1995) Catechol-O-methyltransferase (COMT) in rat brain: immunoelectron microscopic study with an antiserum against rat recombinant COMT protein. Neurosci Lett 187:57\u201360","journal-title":"Neurosci Lett"},{"key":"315_CR20","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0306-4522(94)90379-4","volume":"62","author":"A Kastner","year":"1994","unstructured":"Kastner A, Anglade P, Bounaix C, Damier P, Javoy-Agid F, Bromet N, Agid Y, Hirsch EC (1994) Immunohistochemical study of catechol-O-methyltransferase in the human mesostriatal system. Neuroscience 62:449\u2013457","journal-title":"Neuroscience"},{"key":"315_CR21","first-page":"57","volume":"41","author":"IJ Kopin","year":"1994","unstructured":"Kopin IJ (1994) Monoamine oxidase and catecholamine metabolism. J Neural Transm (Suppl) 41:57\u201367","journal-title":"J Neural Transm (Suppl)"},{"key":"315_CR22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1089\/dna.1991.10.181","volume":"10","author":"K Lundstrom","year":"1991","unstructured":"Lundstrom K, Salminen M, Jalanko A, Savolainen R, Ulmanen I (1991) Cloning and characterization of human placental catechol-O-methyltransferase cDNA. DNA Cell Biol 10:181\u2013189","journal-title":"DNA Cell Biol"},{"key":"315_CR23","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1096\/fj.02-0681fje","volume":"17","author":"M Marvanova","year":"2003","unstructured":"Marvanova M, Menager J, Bezard E, Bontrop RE, Pradier L, Wong G (2003) Microarray analysis of nonhuman primates: validation of experimental models in neurological disorders. FASEB J 17:929\u2013931","journal-title":"FASEB J"},{"key":"315_CR24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0306-4522(02)00556-0","volume":"116","author":"M Matsumoto","year":"2003","unstructured":"Matsumoto M, Weickert CS, Akil M, Lipska BK, Hyde TM, Herman MM, Kleinman JE, Weinberger DR, Kleinman JE (2003) Catechol-O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function. Neuroscience 116:127\u2013137","journal-title":"Neuroscience"},{"key":"315_CR25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00002826-199702000-00007","volume":"20","author":"JW Miller","year":"1997","unstructured":"Miller JW, Shukitt-Hale B, Villalobos-Molina R, Nadeau MR, Selhub J, Joseph JA (1997) Effect of l-dopa and the catechol-O-methyltransferase inhibitor Ro 41\u20130960 on sulfur amino acid metabolites in rats. Clin Neuropharmacol 20:55\u201366","journal-title":"Clin Neuropharmacol"},{"key":"315_CR26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1517\/14728214.11.3.403","volume":"11","author":"JC Morgan","year":"2006","unstructured":"Morgan JC, Sethi KD (2006) Emerging drugs for Parkinson\u2019s disease. Expert Opin Emerg Drugs 11:403\u2013417","journal-title":"Expert Opin Emerg Drugs"},{"key":"315_CR27","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrd2087","volume":"5","author":"AH Schapira","year":"2006","unstructured":"Schapira AH, Bezard E, Brotchie J, Calon F, Collingridge GL, Ferger B, Hengerer B, Hirsch E, Jenner P, Le Nov\u00e8re N, Obeso JA, Schwarzschild MA, Spampinato U, Davidai G (2006) Novel pharmacological targets for the treatment of Parkinson\u2019s disease. Nat Rev Drug Discov 5:845\u2013854","journal-title":"Nat Rev Drug Discov"},{"key":"315_CR28","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/mds.870120616","volume":"12","author":"LA Smith","year":"1997","unstructured":"Smith LA, Gordin A, Jenner P, Marsden CD (1997) Entacapone enhances levodopa-induced reversal of motor disability in MPTP-treated common marmosets. Mov Disord 12:935\u2013945","journal-title":"Mov Disord"},{"key":"315_CR29","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/mds.20317","volume":"20","author":"LA Smith","year":"2005","unstructured":"Smith LA, Jackson MJ, Al-Barghouthy G, Rose S, Kuoppamaki M, Olanow W, Jenner P (2005) Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP-treated drug-naive primates. Mov Disord 20:306\u2013314","journal-title":"Mov Disord"},{"key":"315_CR30","volume-title":"The brain of the common marmoset: a stereotactic atlas","author":"H Stephan","year":"1980","unstructured":"Stephan H (1980) The brain of the common marmoset: a stereotactic atlas. Springer, Berlin"},{"key":"315_CR31","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/cercor\/bhl032","volume":"17","author":"EM Tunbridge","year":"2007","unstructured":"Tunbridge EM, Weickert CS, Kleinman JE, Herman MM, Chen J, Kolachana BS, Harrison PJ, Weinberger DR (2007) Catechol-O-methyltransferase enzyme activity and protein expression in human prefrontal cortex across the postnatal lifespan. Cereb Cortex 17:1206\u20131212","journal-title":"Cereb Cortex"},{"key":"315_CR32","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1432-1033.1997.0452a.x","volume":"243","author":"I Ulmanen","year":"1997","unstructured":"Ulmanen I, Peranen J, Tenhunen J, Tilgmann C, Karhunen T, Panula P, Bernasconi L, Aubry JP, Lundstrom K (1997) Expression and intracellular localization of catechol-O-methyltransferase in transfected mammalian cells. Eur J Biochem 243:452\u2013459","journal-title":"Eur J Biochem"},{"key":"315_CR33","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000133262","volume":"59","author":"R Winqvist","year":"1992","unstructured":"Winqvist R, Lundstrom K, Salminen M, Laatikainen M, Ulmanen I (1992) The human catechol-O-methyltransferase (COMT) gene maps to band q11.2 of chromosome 22 and shows a frequent RFLP with BglI. Cytogenet Cell Genet 59:253\u2013257","journal-title":"Cytogenet Cell Genet"},{"key":"315_CR34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/syn.20089","volume":"55","author":"Z Xu","year":"2005","unstructured":"Xu Z, Cawthon D, McCastlain KA, Slikker W Jr, Ali SF (2005) Selective alterations of gene expression in mice induced by MPTP. Synapse 55:45\u201351","journal-title":"Synapse"},{"key":"315_CR35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/exnr.2001.7726","volume":"171","author":"WQ Zhao","year":"2001","unstructured":"Zhao WQ, Latinwo L, Liu XX, Lee ES, Lamango N, Charlton CG (2001) l-dopa upregulates the expression and activities of methionine adenosyl transferase and catechol-O-methyltransferase. Exp Neurol 171:127\u2013138","journal-title":"Exp Neurol"},{"key":"315_CR36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.expneurol.2007.05.002","volume":"208","author":"M Zubair","year":"2007","unstructured":"Zubair M, Jackson MJ, Tayarani-Binazir K, Stockwell KA, Smith LA, Rose S, Olanow W, Jenner P (2007) The administration of entacapone prevents l-dopa-induced dyskinesia when added to dopamine agonist therapy in MPTP-treated primates. Exp Neurol 208:177\u2013184","journal-title":"Exp Neurol"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-009-0315-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-009-0315-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-009-0315-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T03:15:18Z","timestamp":1739330118000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-009-0315-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,22]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["315"],"URL":"https:\/\/doi.org\/10.1007\/s00702-009-0315-9","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,22]]}}}